El-Shakankery KH - Search Results

1

Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London.

El-Shakankery KH, Kefas J, Palmer K, Houston A, Mukherjee U, Gao K, Tan W, Crusz SM, Flynn MJ, Ledermann JA, Lockley M, McCormack M, MacDonald N, Nicum S, Devlin MJ, Miller RE. El-Shakankery KH, et al. Cancers (Basel). 2024 Oct 24;16(21):3590. doi: 10.3390/cancers16213590. Cancers (Basel). 2024. PMID: 39518031 Free PMC article.

2

Synchronous skull base and spinal metastases in a patient with treatment-resistant, high-grade serous adenocarcinoma of tubo-ovarian origin.

Ziegler J, El-Shakankery KH, Hyare H, Flynn M. Ziegler J, et al. Among authors: el shakankery kh. BMJ Case Rep. 2024 May 21;17(5):e259144. doi: 10.1136/bcr-2023-259144. BMJ Case Rep. 2024. PMID: 38772871

3

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer.

Newhouse R, Nelissen E, El-Shakankery KH, Rogozińska E, Bain E, Veiga S, Morrison J. Newhouse R, et al. Among authors: el shakankery kh. Cochrane Database Syst Rev. 2023 Jul 5;7(7):CD006910. doi: 10.1002/14651858.CD006910.pub3. Cochrane Database Syst Rev. 2023. PMID: 37407274 Free PMC article. Review.

4

Ensuring no patient is lost along the way - a single-centre experience of the clinical genetics referral pathways for Lynch syndrome.

El-Shakankery KH, Balogh P, Grantham M, Minicozzi A, Diamantis N. El-Shakankery KH, et al. Colorectal Dis. 2023 May;25(5):838-842. doi: 10.1111/codi.16496. Epub 2023 Feb 15. Colorectal Dis. 2023. PMID: 36793246

5

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors.

Miller RE, Elyashiv O, El-Shakankery KH, Ledermann JA. Miller RE, et al. Among authors: el shakankery kh. Onco Targets Ther. 2022 Oct 4;15:1105-1117. doi: 10.2147/OTT.S272199. eCollection 2022. Onco Targets Ther. 2022. PMID: 36217436 Free PMC article. Review.

6

PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies.

Miller RE, El-Shakankery KH, Lee JY. Miller RE, et al. Among authors: el shakankery kh. J Gynecol Oncol. 2022 May;33(3):e44. doi: 10.3802/jgo.2022.33.e44. Epub 2022 Mar 8. J Gynecol Oncol. 2022. PMID: 35320891 Free PMC article. Review.

7

Ratio of Oxygen Saturation Index to Guide Management of COVID-19 Pneumonia.

Fink DL, Goldman NR, Cai J, El-Shakankery KH, Sismey GE, Gupta-Wright A, Tai CX. Fink DL, et al. Among authors: el shakankery kh. Ann Am Thorac Soc. 2021 Aug;18(8):1426-1428. doi: 10.1513/AnnalsATS.202008-934RL. Ann Am Thorac Soc. 2021. PMID: 33636094 Free PMC article. No abstract available.

8

COVID-19, the Future Vaccine and What It Means for Cancer Patients on Immunotherapy.

El-Shakankery KH, Kefas J, Miller R. El-Shakankery KH, et al. Front Oncol. 2021 Feb 1;10:631611. doi: 10.3389/fonc.2020.631611. eCollection 2020. Front Oncol. 2021. PMID: 33598436 Free PMC article. No abstract available.

9

A key role for comprehensive geriatric assessment in aortic valve replacement.

El-Shakankery KH, Mieiro L. El-Shakankery KH, et al. BMJ Case Rep. 2020 Dec 22;13(12):e237031. doi: 10.1136/bcr-2020-237031. BMJ Case Rep. 2020. PMID: 33370976 Free PMC article.

10

Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital.

Fink DL, Khan PY, Goldman N, Cai J, Hone L, Mooney C, El-Shakankery KH, Sismey G, Whitford V, Marks M, Thomas S. Fink DL, et al. Among authors: el shakankery kh. QJM. 2021 Dec 20;114(10):699-705. doi: 10.1093/qjmed/hcaa305. QJM. 2021. PMID: 33165573 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters